Included in the formulation
АТХ:B.05.Z.A Hemodialysates (concentrates)
Pharmacodynamics:The solution contains a set of electrolytes containing the lactate buffer and glucose. When hemodialysis is carried out on a salt diffusion gradient, uremic toxins, water and electrolytes are exchanged between dialysis fluid and blood plasma.
Glucose supports energy metabolism and the physiological concentration of carbohydrates.
In the process of hemofiltration, water-soluble slags are removed from the blood.
Pharmacokinetics:Not described.
Indications:It is used for continuous hemofiltration, hemodialysis and hemodiafiltration. It is used for chronic and acute renal failure.
XIV.N17-N19.N18 Chronic Renal Failure
XIV.N17-N19.N17 Acute kidney failure
Contraindications:Metabolic alkalosis, lactic acidosis, hypokalemia, severe cardiovascular insufficiency, age under 18, pregnancy and lactation, individual intolerance.
Carefully:Patient acceptance of metformin.
Pregnancy and lactation:Recommendations for FDA - Category C. Contraindicated in pregnancy and lactation.
Dosing and Administration:Intravenously, the dose is selected taking into account the body weight.
The recommended daily dose is 75 liters.
Side effects:The cardiovascular system: arterial hypertension.
Digestive system: nausea, vomiting.
Musculoskeletal system: convulsions.
Allergic reactions.
Overdose:Cases of overdose are not described.
Treatment is symptomatic.
Interaction:Clinically significant interactions are not described.
Special instructions:In patients with diabetes mellitus, the dose of insulin is corrected due to the increased intake of glucose into the blood plasma.